<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0028-3746</journal-id>
<journal-title><![CDATA[Neumología y cirugía de tórax]]></journal-title>
<abbrev-journal-title><![CDATA[Neumol. cir. torax]]></abbrev-journal-title>
<issn>0028-3746</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Neumología y Cirugía de Tórax; Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas; Sociedad Cubana de Neumología; Sociedad Paraguaya de Neumología; Sociedad Boliviana de Neumología.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0028-37462016000300215</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Cumplimiento de la Guía de Práctica Clínica de EPOC por médicos de primer nivel]]></article-title>
<article-title xml:lang="en"><![CDATA[Adherence to COPD Guidelines in primary care]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González-González]]></surname>
<given-names><![CDATA[Eloisa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fernández-Vega]]></surname>
<given-names><![CDATA[Margarita]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González-Salinas]]></surname>
<given-names><![CDATA[Consuelo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Zenteno]]></surname>
<given-names><![CDATA[Rafael de Jesús]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Secretaría de Salud Centro de Salud ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Nacional Autónoma de México  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2016</year>
</pub-date>
<volume>75</volume>
<numero>3</numero>
<fpage>215</fpage>
<lpage>221</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0028-37462016000300215&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0028-37462016000300215&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0028-37462016000300215&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: La enfermedad pulmonar obstructiva crónica (EPOC) es el problema respiratorio de mayor relevancia e impacto socioeconómico en el mundo. A pesar de ser prevenible y contar con métodos de diagnóstico oportuno, hay evidencia de que es una enfermedad subdiagnosticada y subtratada.  Objetivo: Determinar el cumplimiento de las recomendaciones de las Guías de Práctica Clínica de la EPOC por el personal médico de un centro de salud.  Material y métodos:  Estudio descriptivo y comparativo, transversal y ambispectivo. Se analizaron todos los expedientes de pacientes con EPOC confirmado entre 2014-2015, y se contrastó la historia clínica y notas médicas con las recomendaciones de la Guía de Práctica Clínica (GPC).  Resultados:  Se analizaron 32 notas médicas; de las cuales los médicos residentes cumplieron las recomendaciones en un 49.6%, los médicos familiares adscritos 33.2% y los médicos generales adscritos 31.6%.  Conclusión: Existe un bajo apego a la GPC. El bajo cumplimiento se observó en la mayoría de las recomendaciones de la GPC. Se demostraron diferentes porcentajes de cumplimiento con base en el perfil del médico de primer contacto.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Chronic obstructive pulmonary disease (COPD) is the most relevant cause of respiratory problems with a high social-economic impact in the world. Despite being a preventable disease and have an early diagnosis method, there is evidence of underdiagnosis and undertreatment.  Objective:  To determine the adherence to the recommendations of a COPD Clinical Practice Guidelines (CPG) by primary care physicians at a primary care clinic.  Material and methods:  Descriptive and comparative, cross-sectional and ambispective study, of medical records of patients with confirmed COPD from 2014 to 2015. Each medical history and medical note was compared with the CPG recommendations; for the statistical analysis, descriptive and comparative methods were obtained for each recommendation.  Results:  32 medical notes were analyzed; family medicine residents met 49.6% of the recommendations; staff family medicine specialist followed 33.2% of the recommendations and staff general practitioners 31.6%.  Conclusion:  There is a low adherence to the GPC. This low adherence was observed at most of the recommendations. It was demostrated different percentages of adherence according to physician profile.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Guías]]></kwd>
<kwd lng="es"><![CDATA[EPOC]]></kwd>
<kwd lng="es"><![CDATA[atención primaria]]></kwd>
<kwd lng="en"><![CDATA[Guidelines]]></kwd>
<kwd lng="en"><![CDATA[COPD]]></kwd>
<kwd lng="en"><![CDATA[primary care]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[Enfermedad pulmonar obstructiva crónica (EPOC). [Internet]]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="book">
<collab>National Heart, Lung, and Blood Institute</collab>
<source><![CDATA[¿Qué es la enfermedad pulmonar obstructiva crónica EPOC? [Internet]]]></source>
<year>2014</year>
<publisher-loc><![CDATA[USA ]]></publisher-loc>
<publisher-name><![CDATA[NHLBI]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Menezes]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Perez-Padilla]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Jardim]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study) a prevalence study]]></article-title>
<collab>PLATINO Team</collab>
<source><![CDATA[Lancet]]></source>
<year>2005</year>
<volume>366</volume>
<numero>9500</numero>
<issue>9500</issue>
<page-range>1875-81</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tálamo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[de Oca]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Halbert]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnostic labeling of COPD in five Latin American cities]]></article-title>
<collab>PLATINO Team</collab>
<source><![CDATA[Chest]]></source>
<year>2007</year>
<volume>131</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>60-7</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Guía española de la EPOC (GesEPOC) Actualización 2014]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miravitlles]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soler-Cataluña]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2014</year>
<volume>50</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>1-16</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Salas]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Informe anual de autoevaluación del Director General del Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas [Internet]]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Ciudad de México ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vos]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Flaxman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Naghavi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet]]></source>
<year>2012</year>
<volume>380</volume>
<numero>9859</numero>
<issue>9859</issue>
<page-range>2163-96</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Guías para el Diagnóstico y Tratamiento de la Enfermedad Pulmonar Obstructiva Crónica]]></article-title>
<collab>Cuarto Consenso Mexicano para el Diagnóstico y Tratamiento de la EPOC</collab>
<source><![CDATA[Neumol Cir Torax]]></source>
<year>2012</year>
<volume>71</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>8-89</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miravitlles]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Murio]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Guerrero]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Gisbert]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Decisiones sobre Antibioticoterapia y Farmacoeconomía en la EPOC Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD]]></article-title>
<collab>DAFNE Study Group</collab>
<source><![CDATA[Chest]]></source>
<year>2002</year>
<volume>121</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1449-55</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Costos de atención médica atribuibles al tabaquismo en el IMSS, Morelos]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reynales-Shigematsu]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Juárez-Márquez]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Valdés-Salgado]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Salud Publica Mex]]></source>
<year>2005</year>
<volume>47</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>451-7</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Damiani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dixon]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Managing the pressure. Emergency hospital admissions in London 1991-2001 [Internet]]]></source>
<year>2012</year>
<publisher-loc><![CDATA[London, England ]]></publisher-loc>
<publisher-name><![CDATA[Kings Fund]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Fighting respiratory diseases divided efforts lead to weakness]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez-Padilla]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Stelmach]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Soto-Quiroz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
</person-group>
<source><![CDATA[J Bras Pneumol]]></source>
<year>2014</year>
<volume>40</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>207-10</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Subutilization of COPD guidelines in primary care a pilot study]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laniando-Laborín]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rendón]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alcantar-Schramm]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cazares-Adame]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bauerle]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<source><![CDATA[J Prim Care Community Health]]></source>
<year>2013</year>
<volume>4</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>172-6</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="book">
<collab>Consejo de Salubridad General, IMSS, ISSSTE</collab>
<source><![CDATA[Guía de Referencia Rápida. Diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica [Internet]]]></source>
<year>2011</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[IMSS-037-08]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aisanov]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Bai]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bauerle]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<source><![CDATA[Int J Chron Obstruct Pulmon Dis]]></source>
<year>2012</year>
<volume>7</volume>
<page-range>271-82</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Prevención y control de las enfermedades no transmisibles: Directrices para la atención primaria en entornos con pocos recursos [Internet]]]></source>
<year>2013</year>
<page-range>68</page-range><publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="book">
<collab>National Institute on Drug Abuse</collab>
<source><![CDATA[¿Cuáles son las consecuencias médicas del uso del tabaco? [Internet]]]></source>
<year>2010</year>
<page-range>12</page-range><publisher-loc><![CDATA[USA ]]></publisher-loc>
<publisher-name><![CDATA[National Institute on Drug Abuse]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Partida]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<collab>Consejo Nacional de Población</collab>
<source><![CDATA[Proyecciones de la población de México 2005-2050 [Internet]]]></source>
<year>2006</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Aptitud clínica en médicos familiares apegadas a guías de práctica clínica]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casas]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tapia]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Camacho]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Mex Investig]]></source>
<year>2014</year>
<volume>2</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>100-6</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Estudio IBERPOC en España prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sobradillo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Miravitlles]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>1999</year>
<volume>35</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>159-66</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hacia un programa de prevención y atención primaria de enfermedades respiratorias, AIRE (Acción Integrada por la Respiración)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez-Padilla]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Neumol Cir Torax]]></source>
<year>2012</year>
<volume>71</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>244-9</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="book">
<collab>Centro Nacional de Excelencia Tecnológica en Salud</collab>
<source><![CDATA[Diagnóstico y tratamiento de enfermedad obstructiva [Internet]]]></source>
<year>2009</year>
<publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
